Dear Pascal and Matthias,
I am sorry for the delay of reply, thanks very much for your suggestions on the
glycosylation protein. Now I am trying to do a stable cell line with CHO lec
3.8.2.1 cells, this cell line could express protein with shorter glycans. I
hope several weeks later I could get some better result. I will also try to use
the Glycosylation deficient cell lines.
I am still working on it, thanks again for your valuable advice.
Best regards,
Wei
From: Matthias Zebisch [mailto:matthias.zebi...@bbz.uni-leipzig.de]
Sent: 2011年5月13日 18:15
To: Wei Li
Subject: Re: [ccp4bb] highly glycosylated protein
Try to get hold of GntI deficient HEK293S cells (not commercially available).
Expression takes two weeks but you can achieve comparable yields to HEK293T.
These cells yield very homogenous bands on SDS PAGE. However, check also for O
glycosylation prediction.
As you appear to be from Braunschweig, ask Prof. Sträter in Leipzig. He can
send you these cells.
Good luck,
Matthias
From: Pascal Egea [mailto:pas...@msg.ucsf.edu]
Sent: 2011年5月13日 18:01
To: Wei Li
Cc: CCP4BB@jiscmail.ac.uk
Subject: Re: [ccp4bb] highly glycosylated protein
Hi Wei,
Glycosylation usually stabilize proteins although it is a source of structural
heterogeneity for us crystallographers.Since you are expressing in HEK293
cells, there is a strain of cells that is deficient for glycosylation (it was
designed by Gobind Khorana at the MIT I believe). You may want to try this.
This is particularly useful when you express membrane proteins, it avoids
hyperglycosylation. You may want to try a lightly glycosylated version of your
protein and see if it behaves correctly,
The other extreme solution is to identify all occupied sequons in your protein
and eventually inactivate them by mutagenesis to have a completely
deglycosylated protein. This solution is probably not the best since
glycosylation usually stabilize proteins and may be essential to their
biological function and activity. So it is to be considered with a lot of
caution.
Hope this helps.
--
Pascal F. Egea, PhD
Assistant Professor
UCLA, David Geffen School of Medicine
Department of Biological Chemistry
356 Boyer Hall
office (310)-983-3515
lab (310)-983-3516
email pe...@mednet.ucla.edumailto:pe...@mednet.ucla.edu
Helmholtz-Zentrum für Infektionsforschung GmbH | Inhoffenstraße 7 | 38124
Braunschweig | www.helmholtz-hzi.de
Vorsitzende des Aufsichtsrates: MinDir’in Bärbel Brumme-Bothe,
Bundesministerium für Bildung und Forschung
Stellvertreter: MinDirig Heiko Gevers, Niedersächsisches Ministerium für
Wissenschaft und Kultur
Geschäftsführung: Prof. Dr. Dirk Heinz; Ulf Richter, MBA
Gesellschaft mit beschränkter Haftung (GmbH)
Sitz der Gesellschaft: Braunschweig
Handelsregister: Amtsgericht Braunschweig, HRB 477